Perspective Therapeutics, Inc.
CATX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000728387
In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Perspective Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 48 | 43 | −5 |
| Shares | 17.4M | 15.8M | −1.54M (−8.9%) |
| Value | $13.9M | $9.99M | −$3.87M (−27.9%) |
New holders (3)
Institutions that held Perspective Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 48,421 | $31.0K | 0.00% |
| Total Clarity Wealth Management, Inc. | 4,143 | $3.00K | 0.00% |
| Sonora Investment Management, LLC | 2,000 | $1.00K | 0.00% |
Sold out (8)
Institutions that held Perspective Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Strategic Wealth Advisors Group, LLC | 47,778 | $38.0K |
| Candriam Luxembourg S.C.A. | 34,883 | $28.0K |
| Signaturefd, LLC | 22,500 | $18.0K |
| Harbour Investments, Inc. | 1,900 | $2.00K |
| Tower Research Capital LLC (TRC) | 960 | $1.00K |
| Advisory Services Network, LLC | 1,000 | $1.00K |
| FMR LLC | 56 | $0 |
| Citigroup Inc | 200 | $0 |